1-11 of 11
William K. Oh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing

Li Wang, John P. Sfakianos, Kristin G. Beaumont, Guray Akturk, Amir Horowitz, Robert P. Sebra, Adam M. Farkas, Sacha Gnjatic, Austin Hake, Sudeh Izadmehr, Peter Wiklund, William K. Oh, Peter M. Szabo, Megan Wind-Rotolo, Keziban Unsal-Kacmaz, Xin Yao, Eric Schadt, Padmanee Sharma, Nina Bhardwaj, Jun Zhu, Matthew D. Galsky
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (15): 4287–4300.
https://doi.org/10.1158/1078-0432.CCR-20-4574
Published: 01 August 2021
View article titled, Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing
Open the PDF for Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing in another window
Includes: Supplementary data
Journal Articles

Blood mRNA Expression Profiling Predicts Survival in Patients Treated with Tremelimumab

Yvonne Saenger, Jay Magidson, Bobby Liaw, Ellen de Moll, Sara Harcharik, Yichun Fu, Karl Wassmann, David Fisher, John Kirkwood, William K. Oh, Philip Friedlander
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (12): 3310–3318.
https://doi.org/10.1158/1078-0432.CCR-13-2906
Published: 12 June 2014
View article titled, Blood mRNA Expression Profiling Predicts Survival in Patients Treated with Tremelimumab
Open the PDF for Blood mRNA Expression Profiling Predicts Survival in Patients Treated with Tremelimumab in another window
Includes: Supplementary data
Journal Articles

Inherited Variants in the Chemokine CCL2 Gene and Prostate Cancer Aggressiveness in a Caucasian Cohort

Tong Sun, Lee Gwo-Shu Mary, William K. Oh, Matthew L. Freedman, Mark Pomerantz, Kenneth J. Pienta, Philip W. Kantoff
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (6): 1546–1552.
https://doi.org/10.1158/1078-0432.CCR-10-2015
Published: 15 March 2011
View article titled, Inherited Variants in the Chemokine <em>CCL2</em> Gene and Prostate Cancer Aggressiveness in a Caucasian Cohort
Open the PDF for Inherited Variants in the Chemokine <em>CCL2</em> Gene and Prostate Cancer Aggressiveness in a Caucasian Cohort in another window
Journal Articles

Single-Nucleotide Polymorphisms in p53 Pathway and Aggressiveness of Prostate Cancer in a Caucasian Population

Tong Sun, Gwo-Shu Mary Lee, William K. Oh, Mark Pomerantz, Ming Yang, Wanling Xie, Matthew L. Freedman, Philip W. Kantoff
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (21): 5244–5251.
https://doi.org/10.1158/1078-0432.CCR-10-1261
Published: 31 October 2010
View article titled, Single-Nucleotide Polymorphisms in p53 Pathway and Aggressiveness of Prostate Cancer in a Caucasian Population
Open the PDF for Single-Nucleotide Polymorphisms in p53 Pathway and Aggressiveness of Prostate Cancer in a Caucasian Population in another window
Journal Articles

Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer

Mary-Ellen Taplin, Meredith M. Regan, Yoo-Joung Ko, Glenn J. Bubley, Stephen E. Duggan, Lillian Werner, Tomasz M. Beer, Christopher W. Ryan, Paul Mathew, Shi-Ming Tu, Samuel R. Denmeade, William K. Oh, Oliver Sartor, Christos S. Mantzoros, Roger Rittmaster, Philip W. Kantoff, Steven P. Balk
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 7099–7105.
https://doi.org/10.1158/1078-0432.CCR-09-1722
Published: 11 November 2009
View article titled, Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer
Open the PDF for Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer in another window
Journal Articles

Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality

Kathryn L. Penney, Claudia A. Salinas, Mark Pomerantz, Fredrick R. Schumacher, Christine A. Beckwith, Gwo-Shu Lee, William K. Oh, Oliver Sartor, Elaine A. Ostrander, Tobias Kurth, Jing Ma, Lorelei Mucci, Janet L. Stanford, Philip W. Kantoff, David J. Hunter, Meir J. Stampfer, Matthew L. Freedman
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (9): 3223–3230.
https://doi.org/10.1158/1078-0432.CCR-08-2733
Published: 30 April 2009
View article titled, Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality
Open the PDF for Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality in another window
Includes: Supplementary data
Journal Articles

Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases

Paul Mathew, Peter F. Thall, Corazon D. Bucana, William K. Oh, Michael J. Morris, Donnah M. Jones, Marcella M. Johnson, Sijin Wen, Lance C. Pagliaro, Nizar M. Tannir, Shi-Ming Tu, Anthony A. Meluch, Lon Smith, Lorenzo Cohen, Sun-Jin Kim, Patricia Troncoso, Isaiah J. Fidler, Christopher J. Logothetis
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5816–5824.
https://doi.org/10.1158/1078-0432.CCR-07-1269
Published: 01 October 2007
View article titled, Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases
Open the PDF for Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases in another window
Journal Articles

Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer

Phillip G. Febbo, Aaron Thorner, Mark A. Rubin, Massimo Loda, Philip W. Kantoff, William K. Oh, Todd Golub, Daniel George
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (1): 152–158.
https://doi.org/10.1158/1078-0432.CCR-05-1652
Published: 05 January 2006
View article titled, Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer
Open the PDF for Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Neoadjuvant Docetaxel before Radical Prostatectomy in Patients with High-Risk Localized Prostate Cancer

Phillip G. Febbo, Jerome P. Richie, Daniel J. George, Massimo Loda, Judith Manola, Sridhar Shankar, Agnieska Szot Barnes, Clare Tempany, William Catalona, Philip W. Kantoff, William K. Oh
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (14): 5233–5240.
https://doi.org/10.1158/1078-0432.CCR-05-0299
Published: 20 July 2005
View article titled, Neoadjuvant Docetaxel before Radical Prostatectomy in Patients with High-Risk Localized Prostate Cancer
Open the PDF for Neoadjuvant Docetaxel before Radical Prostatectomy in Patients with High-Risk Localized Prostate Cancer in another window
Journal Articles

A Phase I Study of Estramustine, Weekly Docetaxel, and Carboplatin Chemotherapy in Patients with Hormone-Refractory Prostate Cancer

William K. Oh, Elizabeth Hagmann, Judith Manola, Daniel J. George, Timothy D. Gilligan, Joseph O. Jacobson, Matthew R. Smith, Donald S. Kaufman, Philip W. Kantoff
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 284–289.
https://doi.org/10.1158/1078-0432.284.11.1
Published: 21 January 2005
View article titled, A Phase I Study of Estramustine, Weekly Docetaxel, and Carboplatin Chemotherapy in Patients with Hormone-Refractory Prostate Cancer
Open the PDF for A Phase I Study of Estramustine, Weekly Docetaxel, and Carboplatin Chemotherapy in Patients with Hormone-Refractory Prostate Cancer in another window
Journal Articles

A Phase I Trial of a Recombinant Vaccinia Virus Expressing Prostate-specific Antigen in Advanced Prostate Cancer

Joseph Paul Eder, Philip W. Kantoff, Kristin Roper, GuangXian Xu, Glenn J. Bubley, John Boyden, Linda Gritz, Gail Mazzara, William K. Oh, Philip Arlen, Kwong Y. Tsang, Dennis Panicali, Jeffrey Schlom, Donald W. Kufe
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (5): 1632–1638.
Published: 01 May 2000
View article titled, A Phase I Trial of a Recombinant Vaccinia Virus Expressing Prostate-specific Antigen in Advanced Prostate Cancer
Open the PDF for A Phase I Trial of a Recombinant Vaccinia Virus Expressing Prostate-specific Antigen in Advanced Prostate Cancer in another window